Big Take

Big Take

By Bloomberg and iHeartPodcastsNews
Download on the App Store

Big Take episodes

  • Are We Vaxxed Yet?

    Children have to get vaccinated for less urgent threats—and it works. So why not with Covid? Bloomberg Businessweek's Mark Leydorf reads "Vaccine Mandates for Kids Could Be the Next Big Back-to-School Fight"

    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

    See omnystudio.com/listener for privacy information.

    25 min
  • Can Boeing Make a Comeback After the 737 Max Crisis?

    After calamity and years of restrained ambition under cost-obsessed executives at Boeing, the company that was once a factory of dreams is losing workers to SpaceX and Amazon. Bloomberg's Laura Carlson reads "Boeing’s Talent Exodus Threatens Turnaround"

    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

    See omnystudio.com/listener for privacy information.

    19 min
  • More Variants Are Coming. Will the U.S. Be Ready?

    For much of the pandemic, variant sequencing in the U.S. has been piecemeal, spread between academic research labs, hospitals, philanthropist-funded nonprofits, state health departments, and rare commercial participants.

    Bloomberg's Mark Leydorf reads "Hunting Delta" from Bloomberg Businessweek.

    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

    See omnystudio.com/listener for privacy information.

    20 min
  • Inflation Is Here — How Much Should You Worry?

    Bloomberg Opinion's John Authers reads his story: "Authers’ Indicators Show Undeniable Inflation Reality."

    Inflation is a complex phenomenon that grows from many places. These 35 key measures offer up a more nuanced picture of how markets are positioned, what the official data say and what consumers and businesses are discounting.



    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

    See omnystudio.com/listener for privacy information.

    6 min
  • Moderna's Next Move

    Bloomberg's Renita Young reads "Many New mRNA Applications." This story, by Robert Langreth for Bloomberg Businessweek, explains how Moderna plans to use its mRNA technology to develop shots for influenza, HIV, Zika—and maybe even cancer.

    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

    See omnystudio.com/listener for privacy information.

    26 min

About Big Take

From the publisher's feed

Each weekday, Big Take brings you a story - one big, important story. We talk to Bloomberg journalists around the world, experts and the people at the center of the news to help you understand…